708 related articles for article (PubMed ID: 33775672)
1. Validation of a combined ELISA to detect IgG, IgA and IgM antibody responses to SARS-CoV-2 in mild or moderate non-hospitalised patients.
Cook AM; Faustini SE; Williams LJ; Cunningham AF; Drayson MT; Shields AM; Kay D; Taylor L; Plant T; Huissoon A; Wallis G; Beck S; Jossi SE; Perez-Toledo M; Newby ML; Allen JD; Crispin M; Harding S; Richter AG
J Immunol Methods; 2021 Jul; 494():113046. PubMed ID: 33775672
[TBL] [Abstract][Full Text] [Related]
2. Comparison of six commercially available SARS-CoV-2 antibody assays-Choice of assay depends on intended use.
Nilsson AC; Holm DK; Justesen US; Gorm-Jensen T; Andersen NS; Øvrehus A; Johansen IS; Michelsen J; Sprogøe U; Lillevang ST
Int J Infect Dis; 2021 Feb; 103():381-388. PubMed ID: 33310021
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 antibodies: IgA correlates with severity of disease in early COVID-19 infection.
Zervou FN; Louie P; Stachel A; Zacharioudakis IM; Ortiz-Mendez Y; Thomas K; Aguero-Rosenfeld ME
J Med Virol; 2021 Sep; 93(9):5409-5415. PubMed ID: 33932299
[TBL] [Abstract][Full Text] [Related]
4. A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization.
Peterhoff D; Glück V; Vogel M; Schuster P; Schütz A; Neubert P; Albert V; Frisch S; Kiessling M; Pervan P; Werner M; Ritter N; Babl L; Deichner M; Hanses F; Lubnow M; Müller T; Lunz D; Hitzenbichler F; Audebert F; Hähnel V; Offner R; Müller M; Schmid S; Burkhardt R; Glück T; Koller M; Niller HH; Graf B; Salzberger B; Wenzel JJ; Jantsch J; Gessner A; Schmidt B; Wagner R
Infection; 2021 Feb; 49(1):75-82. PubMed ID: 32827125
[TBL] [Abstract][Full Text] [Related]
5. Validation of dried blood spot sampling for detecting SARS-CoV-2 antibodies and total immunoglobulins in a large cohort of asymptomatic young adults.
Ferentinos P; Snape D; Koivula F; Faustini S; Nicholson-Little A; Stacey M; Gifford R; Parsons I; Lamb L; Greeves J; O'Hara J; Cunningham AF; Woods D; Richter A; O'Shea MK
J Immunol Methods; 2023 Jul; 518():113492. PubMed ID: 37201783
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections.
Huber T; Steininger P; Irrgang P; Korn K; Tenbusch M; Diesch K; Achenbach S; Kremer AE; Werblow M; Vetter M; Bogdan C; Held J
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1983-1997. PubMed ID: 34109500
[TBL] [Abstract][Full Text] [Related]
7. Closing the serological gap in the diagnostic testing for COVID-19: The value of anti-SARS-CoV-2 IgA antibodies.
Infantino M; Manfredi M; Grossi V; Lari B; Fabbri S; Benucci M; Fortini A; Damiani A; Mobilia EM; Panciroli M; Pancani S; Pesce G
J Med Virol; 2021 Mar; 93(3):1436-1442. PubMed ID: 32790181
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients.
Hiki M; Tabe Y; Ai T; Matsue Y; Harada N; Sugimoto K; Matsushita Y; Matsushita M; Wakita M; Misawa S; Idei M; Miida T; Tamura N; Takahashi K; Naito T
PLoS One; 2021; 16(4):e0249449. PubMed ID: 33822809
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of serum IgM and IgG antibodies in COVID-19 patients by enzyme linked immunosorbent assay.
Zhou C; Bu G; Sun Y; Ren C; Qu M; Gao Y; Zhu Y; Wang L; Sun L; Liu Y
J Med Virol; 2021 May; 93(5):2857-2866. PubMed ID: 33331654
[TBL] [Abstract][Full Text] [Related]
10. Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies.
Tré-Hardy M; Wilmet A; Beukinga I; Favresse J; Dogné JM; Douxfils J; Blairon L
J Med Virol; 2021 Feb; 93(2):803-811. PubMed ID: 32667733
[TBL] [Abstract][Full Text] [Related]
11. Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients.
Chansaenroj J; Yorsaeng R; Posuwan N; Puenpa J; Sudhinaraset N; Chirathaworn C; Poovorawan Y
Virol J; 2021 Mar; 18(1):52. PubMed ID: 33750394
[TBL] [Abstract][Full Text] [Related]
12. Serological assay for anti-SARS-CoV-2 antibodies improves sensitivity of diagnosis of COVID-19 patients.
Rostamzadeh D; Mortezagholi S; Alinejad M; Jooya SR; Eskandarian M; Metvaei A; Vafaei S; Aboulghasemi H; Younesi V; Shabani M
Med Microbiol Immunol; 2021 Dec; 210(5-6):283-289. PubMed ID: 34564742
[TBL] [Abstract][Full Text] [Related]
13. Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response.
Shields AM; Faustini SE; Perez-Toledo M; Jossi S; Allen JD; Al-Taei S; Backhouse C; Dunbar LA; Ebanks D; Emmanuel B; Faniyi AA; Garvey M; Grinbergs A; McGinnell G; O'Neill J; Watanabe Y; Crispin M; Wraith DC; Cunningham AF; Drayson MT; Richter AG
BMJ Open Respir Res; 2021 Sep; 8(1):. PubMed ID: 34561239
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal detection of SARS-CoV-2-specific antibody responses with different serological methods.
Emmerich P; von Possel R; Hemmer CJ; Fritzsche C; Geerdes-Fenge H; Menge B; Messing C; Borchardt-Lohölter V; Deschermeier C; Steinhagen K
J Med Virol; 2021 Oct; 93(10):5816-5824. PubMed ID: 34061367
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Dried Blood Spots and Venous Blood for the Detection of SARS-CoV-2 Antibodies in a Population of Nursing Home Residents.
Meyers E; Heytens S; Formukong A; Vercruysse H; De Sutter A; Geens T; Hofkens K; Janssens H; Nys E; Padalko E; Deschepper E; Cools P
Microbiol Spectr; 2021 Oct; 9(2):e0017821. PubMed ID: 34549995
[TBL] [Abstract][Full Text] [Related]
16. Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis.
Indenbaum V; Koren R; Katz-Likvornik S; Yitzchaki M; Halpern O; Regev-Yochay G; Cohen C; Biber A; Feferman T; Cohen Saban N; Dhan R; Levin T; Gozlan Y; Weil M; Mor O; Mandelboim M; Sofer D; Mendelson E; Lustig Y
PLoS One; 2020; 15(11):e0241164. PubMed ID: 33227020
[TBL] [Abstract][Full Text] [Related]
17. Assessment of commercial SARS-CoV-2 antibody assays, Jamaica.
Butterfield TR; Bruce-Mowatt A; Phillips YZR; Brown N; Francis K; Brown J; Walker JP; McKnight NAL; Ehikhametalor K; Taylor DK; Bruce CA; McGrowder D; Wharfe G; Sandiford SL; Thompson TK; Anzinger JJ
Int J Infect Dis; 2021 Apr; 105():333-336. PubMed ID: 33610776
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of spike protein antigens for SARS-CoV-2 serology.
Jagtap S; K R; Valloly P; Sharma R; Maurya S; Gaigore A; Ardhya C; Biligi DS; Desiraju BK; Natchu UCM; Saini DK; Roy R
J Virol Methods; 2021 Oct; 296():114222. PubMed ID: 34197839
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19.
Chiereghin A; Zagari RM; Galli S; Moroni A; Gabrielli L; Venturoli S; Bon I; Rossini G; Saracino IM; Pavoni M; Lafratta S; Deni A; Felici S; Borghi M; Guerra L; Raumer L; Lodi V; Viale P; Attard L; Lazzarotto T;
Front Public Health; 2020; 8():620222. PubMed ID: 33681115
[No Abstract] [Full Text] [Related]
20. Evaluation of commercially available immuno-magnetic agglutination in comparison to enzyme-linked immunosorbent assays for rapid point-of-care diagnostics of COVID-19.
Moeller ME; Fock J; Pah P; Veras AC; Bade M; Donolato M; Israelsen SB; Eugen-Olsen J; Benfield T; Engsig FN
J Med Virol; 2021 May; 93(5):3084-3091. PubMed ID: 33547818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
